{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:52:12Z","timestamp":1789887132903,"version":"4.0.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,12,3]],"date-time":"2015-12-03T00:00:00Z","timestamp":1449100800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s10067-015-3119-3","type":"journal-article","created":{"date-parts":[[2015,12,3]],"date-time":"2015-12-03T02:14:47Z","timestamp":1449108887000},"page":"127-132","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Combination therapy with Bosentan and Sildenafil improves Raynaud\u2019s phenomenon and fosters the recovery of microvascular involvement in systemic sclerosis"],"prefix":"10.1007","volume":"35","author":[{"given":"S.","family":"Bellando-Randone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Lepri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bruni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Blagojevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Radicati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Cometi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"De Paulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Matucci-Cerinic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Guiducci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,3]]},"reference":[{"issue":"8","key":"3119_CR1","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/art.37988","volume":"65","author":"M Matucci-Cerinic","year":"2013","unstructured":"Matucci-Cerinic M, Kahaleh B, Wigley FM (2013) Review: evidence that systemic sclerosis is a vascular disease. Arthritis Rheum 65(8):1953\u201362","journal-title":"Arthritis Rheum"},{"issue":"3","key":"3119_CR2","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/ard.2010.136929","volume":"70","author":"J Avouac","year":"2011","unstructured":"Avouac J, Fransen J, Walker UA, Riccieri V, Smith V, Muller C et al (2011) EUSTAR group preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi consensus study from EULAR scleroderma trials and research group. Ann Rheum Dis 70(3):476\u201381","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"3119_CR3","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/ard.2008.096677","volume":"68","author":"O Kowal-Bielecka","year":"2009","unstructured":"Kowal-Bielecka O, Landew\u00e9 R, Avouac J, Chwiesko S, Miniati I, Czirjak L et al (2009) EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR scleroderma trials and research group (EUSTAR). Ann Rheum Dis 68(5):620\u20138","journal-title":"Ann Rheum Dis"},{"key":"3119_CR4","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/rheumatology\/41.8.843","volume":"41","author":"M MatucciCerinic","year":"2002","unstructured":"MatucciCerinic M, Kahaleh MB (2002) Beauty and the beast. The nitric oxide paradox in systemic sclerosis. Rheumatology (Oxford) 41:843\u20137","journal-title":"Rheumatology (Oxford)"},{"key":"3119_CR5","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1136\/annrheumdis-2012-202836","volume":"72","author":"M Roustit","year":"2013","unstructured":"Roustit M, Blaise S, Allanore Y et al (2013) Phosphodiesterase-5 inhibitors for the treatment of secondary Raynaud\u2019s phenomenon: systematic review and meta-analysis of randomised trials. Ann Rheum Dis 72:1696\u20131699","journal-title":"Ann Rheum Dis"},{"key":"3119_CR6","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1161\/CIRCULATIONAHA.104.523324","volume":"112","author":"R Fries","year":"2005","unstructured":"Fries R, Shariat K, von Wilmowsky H et al (2005) Sildenafil in the treatment of Raynaud\u2019s phenomenon resistant to vasodilatory therapy. Circulation 112:2980\u20135","journal-title":"Circulation"},{"issue":"8","key":"3119_CR7","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1136\/ard.2009.116475","volume":"69","author":"CS Brueckner","year":"2010","unstructured":"Brueckner CS, Becker MO, Kroencke T, Huscher D, Scherer HU, Worm M, Burmester G, Riemekasten G (2010) Effect of sildenafil on digital ulcers in systemic sclerosis: analysis from a single centre pilot study. Ann Rheum Dis 69(8):1475\u20138","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 2","key":"3119_CR8","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/ar2186","volume":"9","author":"D Abraham","year":"2007","unstructured":"Abraham D, Distler O (2007) How does endothelial cell injury start? The role of endothelin in systemic sclerosis. Arthritis Res Ther 9(Suppl 2):S2","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"3119_CR9","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1136\/ard.2007.079921","volume":"67","author":"CP Denton","year":"2008","unstructured":"Denton CP, Pope JE, Peter HH, Gabrielli A, Boonstra A, van den Hoogen FH, TRacleer Use in PAH associated with Scleroderma and Connective Tissue Diseases (TRUST) Investigators et al (2008) Long-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseases. Ann Rheum Dis 67(9):1222\u20138","journal-title":"Ann Rheum Dis"},{"key":"3119_CR10","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1002\/art.20676","volume":"50","author":"J Korn","year":"2004","unstructured":"Korn J, Mayes M, Matucci-Cerinic M et al (2004) Digital ulcers in systemic sclerosis: prevention by treatment with Bosentan, an oral endothelin receptor antagonist. Arthritis Rheum 50:3985\u201393","journal-title":"Arthritis Rheum"},{"key":"3119_CR11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/ard.2010.130658","volume":"70","author":"M Matucci-Cerinic","year":"2011","unstructured":"Matucci-Cerinic M, Denton C, Furst D et al (2011) Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomized, double-blind, placebo-controlled trial. Ann Rheum Dis 70:32\u20138","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"3119_CR12","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3899\/jrheum.131284","volume":"41","author":"M Cutolo","year":"2014","unstructured":"Cutolo M, Ruaro B, Pizzorni C, Ravera F, Smith V, Zampogna G, Paolino S, Seriolo B, Cimmino M, Sulli A (2014) Longterm treatment with endothelin receptor antagonist bosentan and iloprost improves fingertip blood perfusion in systemic sclerosis. J Rheumatol 41(5):881\u20136","journal-title":"J Rheumatol"},{"key":"3119_CR13","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/s10067-012-2074-5","volume":"31","author":"S Guiducci","year":"2012","unstructured":"Guiducci S, Bellando-Randone S, Bruni C et al (2012) Bosentan fosters microvascular de-remodelling in systemic sclerosis. Clin Rheumatol 31:1723\u20131725","journal-title":"Clin Rheumatol"},{"key":"3119_CR14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3899\/jrheum.120416","volume":"40","author":"M Cutolo","year":"2013","unstructured":"Cutolo M, Zampogna G, Vremis L et al (2013) Longterm effects of endothelin receptor antagonism on microvascular damage evaluated by nailfold capillaroscopic analysis in systemic sclerosis. J Rheumatology 40:40\u201345","journal-title":"J Rheumatology"},{"issue":"11","key":"3119_CR15","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F Hoogen Van den","year":"2013","unstructured":"Van den Hoogen F, Khanna D, Fransen J et al (2013) 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis 72(11):1747\u201355","journal-title":"Ann Rheum Dis"},{"key":"3119_CR16","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","volume":"23","author":"Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","year":"1980","unstructured":"Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581\u2013590","journal-title":"Arthritis Rheum"},{"key":"3119_CR17","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/rheumatology\/keq176","volume":"50","author":"G Valentini","year":"2011","unstructured":"Valentini G, Cuomo G, Abignano G et al (2011) Early systemic sclerosis: assessment of clinical and pre-clinical organ involvement in patients with different disease features. Rheumatology (Oxford) 50:317\u201323","journal-title":"Rheumatology (Oxford)"},{"key":"3119_CR18","first-page":"237","volume":"62","author":"M Cutolo","year":"2010","unstructured":"Cutolo M, Pizzorini C, Meroni M et al (2010) The role of nailfold videocapillaroscopy in Raynaud\u2019s phenomenon monitoring and early diagnosis of systemic sclerosis. Reumatismo 62:237\u201347","journal-title":"Reumatismo"},{"key":"3119_CR19","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/annrheumdis-2012-202295","volume":"72","author":"M Matucci-Cerinic","year":"2013","unstructured":"Matucci-Cerinic M, Bellando-Randone S, Lepri G, Bruni C, Guiducci S (2013) Very early versus early disease: the evolving definition of the many faces of systemic sclerosis. Ann Rheum Dis 72:319\u201321","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"3119_CR20","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1136\/annrheumdis-2013-203716","volume":"73","author":"T Minier","year":"2014","unstructured":"Minier T, Guiducci S, Bellando-Randone S, Bruni C, Lepri G, Czirj\u00e1k L et al (2014) Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis. Ann Rheum Dis 73(12):2087\u201393","journal-title":"Ann Rheum Dis"},{"key":"3119_CR21","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1002\/art.20676","volume":"50","author":"JH Korn","year":"2004","unstructured":"Korn JH, Mayes M, MatucciCerinic M et al (2004) Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum 50:3985\u201393","journal-title":"Arthritis Rheum"},{"key":"3119_CR22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/ard.2010.130658","volume":"70","author":"M Matucci-Cerinic","year":"2011","unstructured":"Matucci-Cerinic M, Denton CP, Furst DE, Mayes MD, Hsu VM, Carpentier P et al (2011) Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomized, double-blind, placebo-controlled trial. Ann Rheum Dis 70:32\u20138","journal-title":"Ann Rheum Dis"},{"key":"3119_CR23","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1016\/j.jaad.2011.04.029","volume":"65","author":"P Moinzadeh","year":"2011","unstructured":"Moinzadeh P, Hunzelmann N, Krieg T (2011) Combination therapy with an endothelin-1 receptor antagonist (bosentan) and a phosphodiesterase V inhibitor (sildenafil) for the management of severe digital ulcerations in systemic sclerosis. J Am Acad Dermatol 65:e102\u20134","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"3119_CR24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4081\/reumatismo.2013.79","volume":"65","author":"E Catarsi","year":"2013","unstructured":"Catarsi E, Doveri M, Tavoni A (2013) Bosentan and sildenafil: successful treatment in a sclerodermic patient with refractory ulcers. Reumatismo 65(2):79\u201381","journal-title":"Reumatismo"},{"issue":"6","key":"3119_CR25","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/rheumatology\/ket312","volume":"53","author":"S Cappelli","year":"2014","unstructured":"Cappelli S, Bellando-Randone S, Guiducci S, Matucci-Cerinic M (2014) Is immunosuppressive therapy the anchor treatment to achieve remission in systemic sclerosis? Rheumatology (Oxford) 53(6):975\u201387","journal-title":"Rheumatology (Oxford)"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-015-3119-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-015-3119-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-015-3119-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T04:48:37Z","timestamp":1567399717000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-015-3119-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,3]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["3119"],"URL":"https:\/\/doi.org\/10.1007\/s10067-015-3119-3","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,3]]}}}